Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health

Open Access 01-12-2009 | Research article

Age-specific symptom prevalence in women 35–64 years old: A population-based study

Authors: Annika Bardel, Mari-Ann Wallander, Hans Wedel, Kurt Svärdsudd

Published in: BMC Public Health | Issue 1/2009

Login to get access

Abstract

Background

Symptom prevalence is generally believed to increase with age. The aim of this study was to evaluate the age specific prevalence of 30 general symptoms among Swedish middle-aged women.

Methods

A cross-sectional postal questionnaire study in seven Swedish counties in a random sample of 4,200 women 35–64 years old, with 2,991 responders. Thirty general symptoms included in the Complaint Score subscale of the Gothenburg Quality of Life Instrument were used.

Results

Four groups of age specific prevalence patterns were identified after adjustment for the influence of educational level, perceived health and mood, body mass index, smoking habits, use of hormone replacement therapy, and use of other symptom relieving therapy. Only five symptoms (insomnia, leg pain, joint pain, eye problems and impaired hearing) increased significantly with age. Eleven symptoms (general fatigue, headache, irritability, melancholy, backache, exhaustion, feels cold, cries easily, abdominal pain, dizziness, and nausea) decreased significantly with age. Two symptoms (sweating and impaired concentration) had a biphasic course with a significant increase followed by a significant decrease. The remaining twelve symptoms (difficulty in relaxing, restlessness, overweight, coughing, breathlessness, diarrhoea, chest pain, constipation, nervousness, poor appetite, weight loss, and difficulty in urinating) had stable prevalence with age.

Conclusion

Symptoms did not necessarily increase with age instead symptoms related to stress-tension-depression decreased.
Appendix
Available only for authorised users
Literature
1.
Tibblin G, Bengtsson C, Furunes B, Lapidus L: Symptoms by age and sex. The population studies of men and women in Gothenburg, Sweden. Scand J Prim Health Care. 1990, 8: 9-17. 10.3109/02813439008994923.CrossRefPubMed
2.
Furunes B, Bengtsson C, Lapidus L: Subjectively experienced symptoms in relation to socio-economic factors in women. Eur J Epidemiol. 1996, 12: 617-24. 10.1007/BF00499461.CrossRefPubMed
3.
Stadberg E, Mattsson LA, Milsom I: The prevalence and severity of climacteric symptoms and use of different treatment regimens in a Swedish population. Acta Obstet Gynecol Scand. 1997, 76: 442-48. 10.3109/00016349709047826.CrossRefPubMed
4.
Ivarsson T, Spetz AC, Hammar M: Physical exercise and vasomotor symptoms in postmenopausal women. Maturitas. 1998, 29: 139-46. 10.1016/S0378-5122(98)00004-8.CrossRefPubMed
5.
Hunter MS: Predictors of menopausal symptoms: psychosocial aspects. Baillieres Clin Endocrinol Metab. 1993, 7: 33-45. 10.1016/S0950-351X(05)80269-1.CrossRefPubMed
6.
Pennebaker JW: The psychology of physical symptoms. 1982, Berlin: Springer VerlagCrossRef
7.
Ladwig KH, Marten-Mittag B, Formanek B, Dammann G: Gender differences of symptom reporting and medical health care utilization in the German population. Eur J Epidemiol. 2000, 16: 511-18. 10.1023/A:1007629920752.CrossRefPubMed
8.
Kandrack MA, Grant KR, Segall A: Gender differences in health related behaviour: some unanswered questions. Soc Sci Med. 1991, 32: 579-90. 10.1016/0277-9536(91)90293-L.CrossRefPubMed
9.
Maartens LW, Leusink GL, Knottnerus JA, Pop VJ: Hormonal substitution during menopause: what are we treating?. Maturitas. 2000, 34: 113-18. 10.1016/S0378-5122(99)00093-6.CrossRefPubMed
10.
Tibblin G, Tibblin B, Peciva S, Kullman S, Svärdsudd K: "The Göteborg quality of life instrument" – an assessment of well-being and symptoms among men born 1913 and 1923. Methods and validity. Scand J Prim Health Care Suppl. 1990, 1: 33-38.PubMed
11.
Nordic Statistics on Medicines 1975–1977, parts I & II. 1977, Helsinki and Oslo: Nordic Council on Medicines
12.
SAS Institute Inc: SAS, Ver.6.12. 1989, Cary, NC: SAS Institute Inc
13.
Burman K: Läkemedelsstatistik 1996. 1996, Stockholm, Sweden: Text & Tryck
14.
15.
Bardel A, Wallander MA, Svärdsudd K: Hormone replacement therapy and symptom reporting in menopausal women: a population-based study of 35–65-year-old women in mid-Sweden. Maturitas. 2002, 41: 7-15. 10.1016/S0378-5122(01)00254-7.CrossRefPubMed
16.
Gorman JM: Gender differences in depression and response to psycho-tropic medication. Gend Med. 2006, 3: 93-109. 10.1016/S1550-8579(06)80199-3.CrossRefPubMed
17.
Björkelund C, Bengtsson C, Lissner L, Rödström K: Women's sleep: longitudinal changes and secular trends in a 24-years perspective. Results of the population study of women in Gothenburg, Sweden. Sleep. 2002, 25: 894-96.PubMed
18.
Wallander MA, Johansson S, Ruigómez A, García Rodríguez LA, Jones R: Morbidity associated with sleep disorder in primary care: a longitudinal cohort study. Prim Care Companion J Clin Psychiatry. 2007, 9 (5): 338-345.CrossRefPubMedPubMedCentral
19.
Symmons DP, Barrett EM, Bankhead CR, Scott DG, Silman AJ: The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol. 1994, 33: 735-39. 10.1093/rheumatology/33.8.735.CrossRefPubMed
20.
Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, Kington RS, Lane NE, Nevitt MC, Zhang Y, Sowers M, McAlindon T, Spector TD, Poole AR, Yanovski SZ, Ateshian G, Sharma L, Buckwalter JA, Brandt KD, Fries JF: Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000, 133: 635-46.CrossRefPubMed
21.
Lindqvist P, Andersson K, Sundh V, Lissner L, Björkelund C, Bengtsson C: Concurrent and separate effects of body mass index and waist-to-hip ratio on 24-year mortality in the Popoulation Study of Women in Gothenburg: evidence of age-dependency. Eur J Epidemiol. 2006, 21 (11): 789-94. 10.1007/s10654-006-9074-1.CrossRefPubMed
22.
Greendale GA, Lee NP, Arriola ER: The menopause. Lancet. 1999, 353 (9152): 571-80. 10.1016/S0140-6736(98)05352-5.CrossRefPubMed
23.
Hammar M, Berg G, Lindgren R: Vilka somatiska symptom uppträder vid hormonbortfall kring och efter menopausen och hur vanliga är dessa? (What somatic symptoms occur at hormone reduction around and after the menopause, and how common are they/authors transation). Subtitutionsbehanding i klimakteriet: aktuella synpunkter (Substitution treatment in the menopause: current views). Edited by: Sjöberg NO. 1998, Stockholm, Sweden: Swedish Society of Medicine
24.
Hunter M, Battersby R, Whitehead M: Relationships between psychological symptoms, somatic complaints and menopausal status. Maturitas. 1986, 8 (3): 217-28. 10.1016/0378-5122(86)90029-0.CrossRefPubMed
25.
Jaszmann L: Epidemiology of climacteric and postclimacteric complaints. Ageing and Estrogens. Edited by: Van Keep P, Lauritzen C. 1973, Basel: Karger, 22-34.
26.
Hardy R, Kuh D: Change in psychological and vasomotor symptom reporting during the menopause. Soc Sci Med. 1988, 55 (11): 1975-88. 10.1016/S0277-9536(01)00326-4.CrossRef
27.
Holte A: Influences of natural menopause on health complaints: a prospective study of healthy Norwegian women. Maturitas. 1992, 14 (2): 127-41. 10.1016/0378-5122(92)90005-O.CrossRefPubMed
28.
Stadberg E, Mattsson LA, Milsom I: Factors associated with climacteric symptoms and the use of hormone replacement therapy. Acta Obstet Gynecol Scand. 2000, 79 (4): 286-92. 10.1034/j.1600-0412.2000.079004286.x.CrossRefPubMed
29.
Aegidius KL, Zwart JA, Hagen K, Schei B, Stovner LJ: Hormone replacement therapy and headache prevalence in postmenopausal women. The Head-HUNT study. Eur J Neurol. 2007, 14 (1): 73-8. 10.1111/j.1468-1331.2006.01557.x.CrossRefPubMed
30.
Dixon A, Gatchel RJ: Gender and parental status as predictors of chronic low back pain disability: a prospective study. J Occupational Rehab. 1999, 9 (3): 195-200. 10.1023/A:1021353818130.CrossRef
31.
Papageorgiou AC, Croft PR, Ferry S, Jayson MI, Silman AJ: Estimating the prevalence of low back pain in the general population. Evidence from the South Manchester Back Pain Survey. Spine. 1995, 20: 1889-94. 10.1097/00007632-199509000-00009.CrossRefPubMed
32.
Croft PR, Macfarlane GJ, Papageorgiou AC, Thomas E, Silman AJ: Outcome of low back pain in general practice: a prospective study. BMJ. 1998, 316: 1356-59.CrossRefPubMedPubMedCentral
33.
Wallander MA, Johansson S, Ruigómez A, García Rodríguez LA: Unspecified abdominal pain in primary care: the role of gastrointestinal morbidity. Int J Clin Pract. 2007, 61: 1663-70. 10.1111/j.1742-1241.2007.01529.x.CrossRefPubMed
Metadata
Title
Age-specific symptom prevalence in women 35–64 years old: A population-based study
Authors
Annika Bardel
Mari-Ann Wallander
Hans Wedel
Kurt Svärdsudd
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2009
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-9-37